TOLL-LIKE RECEPTOR 2 AND 4 RESPONSE AND EXPRESSION ON MONOCYTES DECREASE RAPIDLY IN PATIENTS UNDERGOING ARTERIAL SURGERY AND ARE RELATED TO PREOPERATIVE SMOKING
暂无分享,去创建一个
W. Buhre | G. Pasterkamp | E. V. van Dongen | D. D. de Kleijn | I. Hoefer | J. D. de Vries | D. Versteeg | S. Flier | Erik Dol
[1] Sue E. Poynter,et al. INDUCTION OF ENDOTOXIN TOLERANCE ENHANCES BACTERIAL CLEARANCE AND SURVIVAL IN MURINE POLYMICROBIAL SEPSIS , 2008, Shock.
[2] J. Sluijter,et al. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. , 2008, Atherosclerosis.
[3] P. Stella,et al. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve , 2007, Heart.
[4] B. Husain,et al. MICROCIRCULATORY ALTERATIONS OF HEPATIC AND MESENTERIC MICROCIRCULATION IN ENDOTOXIN TOLERANCE , 2007, Shock.
[5] T. van der Poll,et al. LOCAL STIMULATION OF α7 CHOLINERGIC RECEPTORS INHIBITS LPS-INDUCED TNF-α RELEASE IN THE MOUSE LUNG , 2007, Shock.
[6] T. Billiar,et al. EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE , 2006, Shock.
[7] S. Akira,et al. Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.
[8] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[9] J. Gidday. Cerebral preconditioning and ischaemic tolerance , 2006, Nature Reviews Neuroscience.
[10] L. Larsson,et al. Elevated concentrations of endotoxin in indoor air due to cigarette smoking. , 2006, Journal of environmental monitoring : JEM.
[11] T. van der Poll,et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. , 2006, Gastroenterology.
[12] P. Tobias,et al. Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.
[13] L. Ulloa. The vagus nerve and the nicotinic anti-inflammatory pathway , 2005, Nature Reviews Drug Discovery.
[14] H. Berthoud,et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway , 2005, Nature Immunology.
[15] T. van der Poll,et al. Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis , 2005, Critical care medicine.
[16] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[17] G. Pasterkamp,et al. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. , 2005, Cardiovascular research.
[18] P. Shah,et al. Role of Toll-like receptors in atherosclerosis. , 2004, Circulation research.
[19] D. Weissman,et al. Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] G. Pasterkamp,et al. Functional role for toll-like receptors in atherosclerosis and arterial remodeling , 2004, Current opinion in lipidology.
[21] R. McIntyre,et al. Hemorrhage-induced acute lung injury is TLR-4 dependent. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] B. Beutler,et al. Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.
[23] D. Reen,et al. HSP60 induces self‐tolerance to repeated HSP60 stimulation and cross‐tolerance to other pro‐inflammatory stimuli , 2004, European journal of immunology.
[24] P. Quax,et al. Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling , 2004, Circulation.
[25] R. Busuttil,et al. Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.
[26] J. Oyama,et al. Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice , 2003, Circulation.
[27] M. Kaminishi,et al. Sublethal endotoxin administration evokes super-resistance to systemic hypoxia in rats. , 2003, The Journal of trauma.
[28] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[29] J. Sluijter,et al. In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions , 2002, Circulation.
[30] W. Buurman,et al. In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation1 , 2002, The Journal of Immunology.
[31] A. Shigematsu,et al. Surgical Stress Induces Endotoxin Hyporesponsiveness and an Early Decrease of Monocyte mCD14 and HLA-DR Expression During Surgery , 2001, Anesthesia and analgesia.
[32] J. Pugin,et al. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.
[33] C. Janeway,et al. The Toll receptor family and microbial recognition. , 2000, Trends in microbiology.
[34] J. Rodriguez,et al. Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappaB alterations not present in C3H/HeJ mice. , 2000, The Journal of trauma.
[35] S. Akira,et al. Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.
[36] D. Gouma,et al. Minimally Invasive Surgery Induces Endotoxin-Tolerance in the Absence of Detectable Endotoxemia , 1998, Journal of Clinical Immunology.
[37] L. O’Neill,et al. Signal transduction pathways activated by the IL‐1 receptor family: ancient signaling machinery in mammals, insects, and plants , 1998, Journal of leukocyte biology.
[38] R. Ross,et al. Atherosclerosis is an Inflammatory Disease , 1998 .
[39] E. Faist,et al. Update on the Mechanisms of Immune Suppression of Injury and Immune Modulation , 1996, World Journal of Surgery.
[40] J. Cavaillon. The nonspecific nature of endotoxin tolerance. , 1995, Trends in microbiology.
[41] D. Wilmore,et al. Induced hyporesponsiveness in rat Kupffer cells is not specific for lipopolysaccharide. , 1994, Immunology.
[42] J. Mier,et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. , 1993, Journal of immunology.
[43] J. Cavaillon,et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.
[44] E. Roth,et al. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. , 2006, Shock.
[45] www.elsevier.com/locate/cardiores Review C-reactive protein in atherosclerosis: A causal factor? , 2006 .
[46] G. Germann,et al. Remote ischemic preconditioning of flaps: A review , 2005, Microsurgery.
[47] M. West,et al. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. , 2003, Surgical infections.